Skip to main content

D. E. Shaw & Co., Inc.

Position in TBPH — Theravance Biopharma, Inc.

CIK 1009207 New York, NY

Position in TBPH

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$15,484,100
-$8,089,395 QoQ
Shares Held
954,042
-24.3% QoQ
Ownership
1.85%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TBPH Over Time

Shares Held

Position Value (USD)

Derivatives in TBPH

reported options exposure · as of Mar 31, 2020
CallValue
$0
CallShares
0
PutValue
$924,400
PutShares
40,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

D. E. Shaw & Co., Inc. holds $4,328,350,520 across 180 Biotechnology names. TBPH ranks #52 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TBPH

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $15,484,100 954,042
2025-12-31 $23,573,495 1,259,941
2025-09-30 $17,655,955 1,209,312
2025-06-30 $11,049,478 1,001,766
2025-03-31 $8,218,296 920,302
2024-12-31 $7,847,403 833,943
2024-09-30 $6,164,004 764,765
2024-06-30 $6,428,518 758,080
2024-03-31 $7,010,817 781,585
2023-12-31 $9,567,577 851,208
2023-09-30 $5,950,910 689,561
2023-06-30 $7,391,079 714,114
2023-03-31 $11,012,673 1,014,993
2022-12-31 $17,645,132 1,572,650
2022-09-30 $16,094,187 1,587,198
2022-06-30 $12,506,396 1,380,397
2022-03-31 $11,845,241 1,239,042
2021-12-31 $9,684,915 876,463
2021-09-30 $3,108,377 420,051
2021-03-31 $1,143,245 56,014
2020-12-31 $623,016 35,060
2020-09-30 $1,020,623 69,031
2020-06-30 $1,574,753 75,024
2020-03-31 $924,400 40,000
2020-03-31 $206,857 8,951